[April 16, 2018] |
 |
Powerhouse Life Sciences Team Joins Goodwin
Global 50 law firm Goodwin announced today that a team of four partners
will join its premier Life
Sciences practice. Graham Defries and Andrew Harrow will join
Goodwin's London
office and formally establish the firm's European Life Sciences
practice. Kristopher Brown and Jonathan Schur will join the New
York office and expand the firm's award-winning national practice.
All four will start at Goodwin upon completion of their notice period.
"Graham, Kristopher, Jonathan, and Andrew make up a truly unique,
cross-border team that represents the life sciences industry's key
players - from emerging and later stage biotechnology and pharmaceutical
companies across their full life cycles, to boards and venture firms
across all of their dealmaking needs - on both continents," said Mitchell
Bloom, Chair of Goodwin's Life Sciences practice. "The type of deals
they focus on, their networks, a loyal client following, and industry
expertise make this team a perfect fit for our growing life sciences
platform and significantly expand our cross-border capabilities. We are
thrilled that Graham, Kristopher, Jonathan, and Andrew have chosen to
join the Goodwin partnership."
-
Kristopher Brown negotiates and structures private equity,
venture capital and public capital markets financing transactions, and
advises on corporate and transactional matters for numerous financial
and corporate strategic investors as well as emerging growth companies.
-
Graham Defries represents boards and venture firms and works
across all key life sciences markets in Europe. He advises clients on
private equity investments and exits, mergers and acquisitions,
corporate finance, and collaboration an licensing transactions.
-
Andrew Harrow provides counsel on a wide range of U.K. and
cross-border transactions including joint ventures, mergers and
acquisitions, reorganizations, privatizations, IPOs and fundraisings
for listed and private companies internationally, as well as on
general corporate matters.
-
Jonathan Schur advises pharmaceutical and medical device
companies in structuring mergers and acquisitions, divestitures,
licensing and distribution arrangements, joint ventures, cooperative
development, and marketing relationships. He previously served as the
Co-Managing Partner of an international law firm's Paris office.
"Over the past several years, we have significantly expanded Goodwin's
European platform, more than doubling our London presence and opening
offices in Paris and Frankfurt to meet client demand across the firm's
key verticals in real estate, private equity and technology," said David
Evans, Chair of Goodwin's European offices. "With this outstanding
team of life sciences partners, we've found the perfect opportunity to
extend the reach of Goodwin's premier life sciences practice, another
key vertical for us, into Europe. Since the U.K. is the largest life
sciences market in Europe, beginning our regional build-out in London
was the natural next step. We are pleased to welcome Graham and Andrew,
and their New York-based colleagues Kristopher and Jonathan."
"This is a unique opportunity, together with some of my longstanding
colleagues in London and the U.S., to launch the European life sciences
practice of the gold standard life sciences law firm in the U.S.," said
Defries. "I am excited to be joining the preeminent global team at
Goodwin to help develop the firm's transactional European life sciences
practice, and to continue to work with private equity sponsor clients on
M&A transactions."
"With our long history of collaborating with our colleagues in London,
and Goodwin's deep U.S. expertise and resources, we are thrilled to
offer global life sciences and technology clients the complete suite of
legal services they require," said Brown.
Goodwin's Life Sciences practice was named "Practice
Group of the Year" for the past two years by Law360, which called
Goodwin "a top choice for high-profile pharmaceutical clients,
particularly in licensing deals, mergers and acquisitions, and initial
public offerings." Goodwin has been recognized by U.S. News and World
Report - Best Lawyers as "Biotech
Firm of Year" for five out of last six years. In addition, the firm
was named "2017
IP Law Firm of the Year" by LMG Life Sciences.
About Goodwin At Goodwin, we use law to achieve
unprecedented results for our clients. Our 1,000 plus lawyers across the
United States, Europe, and Asia excel at complex transactions,
high-stakes litigations and world-class advisory services in the
financial, life sciences, private equity, real estate, and technology
industries. We partner with our clients to practice law with integrity,
ingenuity, agility, and ambition. To learn more, visit us at www.goodwinlaw.com
and follow us on Twitter (News - Alert) at @goodwinlaw
and on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180416005877/en/
[ Back To TMCnet.com's Homepage ]
|